DOCSLIB.ORG

2021 Enhanced High Deductible Health Plan (HDHP) Preventive Therapy Drug List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2021 Enhanced High Deductible Health Plan (HDHP) Preventive Therapy Drug List 2021 Enhanced High Deductible Health Plan (HDHP) Preventive Therapy Drug List This enhanced list includes both brand and generic products used to manage additional disease states. The enhanced offering includes both insulin and oral therapy for diabetes, inhalers for asthma and COPD, and additional preventative supplies supported by the 2019 IRS publication. ANAPHYLAXIS PREVENTION Sympazan clonidine HCl Adrenalin tiagabine HCl digoxin epinephrine autoinjector topiramate diltiazem HCl EpiPen Trokendi XR diltiazem HCl CD EpiPen Jr valproic acid diltiazem HCl ER Symjepi Vigabatrin doxazosin mesylate vigadrone enalapril maleate ANTICOAGULANTS Vimpat enalapril maleate/HCTZ Bevyxxa zonisamide eplerenone dalteparin sodium felodipine ER Eliquis BLOOD PRESSURE MONITORING fosinopril sodium enoxaparin sodium Blood Pressure Monitor fosinopril sodium/HCTZ fondaparinux sodium guanfacine HCl Fragmin CARDIOVASCULAR - ANTI-ANGINAL hydralazine HCl Pradaxa isosorbide dinitrate irbesartan Savaysa Isosorbide Dinitrate ER irbesartan/HCTZ warfarin sodium isosorbide mononitrate isradipine Xarelto isosorbide mononitrate ER labetalol HCl nitroglycerin lisinopril ANTI-CONVULSANTS nitroglycerin ER lisinopril/HCTZ Aptiom nitroglyerin lingual losartan potassium Banzel nitroglycerin transdermal losartan potassium/HCTZ Briviact ranolazine ER methyldopa carbamazepine methyldopa/HCTZ carbamazepine ER CARDIOVASCUALR - ANTI-ARRHYTHMIC metoprolol succinate ER Celontin amiodarone HCl metoprolol tartrate clobazam disopyramide phosphate Metoprolol/HCTZ clonazepam dofetilide minoxidil clonazepam odt flecainide acetate moexipril HCl Diacomit Mexiletine HCl moexipril/HCTZ Diastat Acudial Multaq nadolol divalproex sodium propafenone HCl nadolol/bendroflumethiazide divalproex sodium DR quinidine gluconate CR nicardipine HCl divalproex sodium ER Quinidine Sulfate nifedipine epitol nifedipine ER ethosuximide CARDIOVASCULAR - nimodipine felbamate ANTI-HYPERTENSIVES nisoldipine ER Fycompa acebutolol HCl olmesartan gabapentin aliskiren olmesartan/amlodipine lamotrigine amlodipine besylate olmesartan/HCTZ lamotrigine ER amlodipine besylate/benazpril perindopril erbumine lamotrigine ODT amlodipine besylate/valsartan phenoxybenzamine HCl levetiracetam amlodipine/olmesartan med pindolol Nayzilam amlodipine/valsartan/HCTZ prazosin HCl oxcarbazepine atenolol propranolol HCl Oxtellar XR atenolol/chlorthalidone propranolol/HCTZ Peganone benazepril HCl quinapril HCl phenobarbital benazepril HCl/HCTZ quinapril/HCTZ phenytoin betaxolol HCl ramipril phenytoin sodium extended bisoprolol fumarate sotalol HCl pregabalin bisoprolol fumarate/HCTZ sotalol HCl (AF) primidone candesartan cilexetil telmisartan Qudexy XR candesartan cilexetil/HCTZ telmisartan/amlodipine roweepra captopril telmisartan/HCTZ roweepra XR captopril/HCTZ terazosin HCl Spritam carvedilol tiadylt ER KEY: CR = controlled release | DR = delayed release | ER = extended release HCl = hydrochloride | HCTZ = hydrochlorothiazide | HFA = hydrofluoroalkane LA = long acting | ODT = oral disintegrating tablet | XR = extended release timolol maleate diazoxide Insulin syringes trandolapril Farxiga Lancets trandolapril/verapamil HCl Fiasp Lancing devices valsartan glimepiride valsartan/HCTZ glipizide GOUT PREVENTION verapamil HCl ER glipizide ER allopurinol Verapamil HCl SR glipizide/metformin HCl verapamil HCl Glucagen Hypokit MENTAL HEALTH Glucagon Emergency Kit Abilify Maintena CARDIOVASCULAR - CHOLESTEROL glyburide acamprosate calcium DR MEDICATION glyburide micronized amitriptyline HCl Antara glyburide/metformin HCl Amoxapine atorvastatin calcium Glyxambi Aplenzin cholestyramine Gvoke aripiprazole cholestyramine light Humalog aripiprazole injection colesevelam HCl Humalog Mix 50/50 aripiprazole ODT colestipol HCl Humalog Mix 75/25 Aristada ezetimibe Humulin 70/30 Belbuca ezetimibe/simvastatin Humulin N Bunavail fenofibrate Humulin R buprenorphine HCl Fibricor Humulin R U-500 buprenorphine HCl/naloxone fluvastatin Insulin Aspart bupropion HCl fluvastatin sodium ER Insulin Aspart Protamine bupropion HCl SR gemfibrozil Insulin Lispro Caplyta Livalo Insulin Lispro Protamine chlorpromazine HCl lovastatin Invokana citalopram hydrobromide niacin ER Januvia clomipramine HCl pravastatin sodium Jardiance clozapine rosuvastatin calcium Lantus clozapine ODT simvastatin Levemir desipramine HCl Vascepa metformin extended release desipramine HCl Zypitamag metformin HCl desvenlafaxine ER miglitol disulfiram CARDIOVASCULAR - DIURETICS nateglinide duloxetine HCl acetazolamide Novolin 70/30 Emsam acetazolamide ER Novolin N escitalopram oxalate amiloride HCl Novolin R Fanapt amiloride/HCTZ Novolog Fazaclo bumetanide Novolog Mix 70/30 Fetzima chlorothiazide Onglyza Fluoxetine DR chlorthalidone Ozempic fluoxetine HCl ethacrynic acid pioglitazone HCl/metformin fluphenazine decanoate furosemide pioglitazone HCl/glimepiride fluphenazine HCl hydrochlorothiazide (HCTZ) pioglitazone HCl fluvoxamine maleate indapamide Qtern fluvoxamine maleate ER methazolamide repaglinide haloperidol metolazone Repaglinide/Metformin HCl haloperidol decanoate spironolactone Rybelsus imipramine HCl spironolactone/HCTZ Segluromet imipramine pamoate torsemide Soliqua Invega Trinza triamterene Steglatro Latuda triamterene/HCTZ Steglujan Lithium Symlinpen lithium carbonate DIABETES Tanzeum lithium carbonate ER acarbose Tolazamide loxapine succinate Adlyxin Tolbutamide Maprotiline HCl Admelog Toujeo Marplan Afrezza Tradjenta mirtazapine Alogliptin Tresiba mirtazapine ODT Alogliptin/Metformin HCl Trijardy XR Molindone HCl Alogliptin/Pioglitazone Trulicity nefazodone HCl Apidra Victoza nortriptyline HCl Avandia Xultophy olanzapine Baqsimi olanzapine ODT Basaglar Kwikpen DIABETES SUPPLIES paliperidone ER Bydureon Blood glucose test strips paroxetine HCl Byetta Glucometer perphenazine Chlorpropamide Insulin pen needles Perseris KEY: CR = controlled release | DR = delayed release | ER = extended release HCl = hydrochloride | HCTZ = hydrochlorothiazide | HFA = hydrofluoroalkane LA = long acting | ODT = oral disintegrating tablet | XR = extended release ELIXIR • 2021 ENHANCED HDHP LIST | 2 phenelzine sulfate Alvesco TRANSPLANT ANTI-REJECTION Probuphine Implant Kit Anoro Ellipta Astagraf XL prochlorperazine Arcapta Neohaler Azasan prochlorperazine maleate Armonair Respiclick azathioprine protriptyline HCl Arnuity Ellipta basiliximab quetiapine fumarate Asmanex HFA belatacept injection quetiapine fumarate ER Asmanex Twisthaler cyclosporine Rexulti Atrovent HFA cyclosporine modified Risperdal Consta Bevespi Aerosphere Envarsus XR risperidone Breo Ellipta everolimus risperidone ODT Brovana mycophenolate mofetil Saphris budesonide mycophenolic acid DR Secuado Budesonide/Formoterol Fumurate Nulojix sertraline HCl Combivent Respimat Prograf Sublocade Duaklir Pressair Sandimmune thioridazine HCl Dulera sirolimus thiothixene Elixophyllin tacrolimus tranylcypromine sulfate Flovent Diskus Zortress trazodone HCl Flovent HFA trifluoperazine HCl fluticasone propionate/salmeterol WEIGHT LOSS AGENTS trimipramine maleate Incruse Ellipta benzphetamine HCl Trintellix ipratropium bromide Contrave venlafaxine HCl ipratropium bromide/albuterol diethylpropion HCl ER venlafaxine HCl ER levalbuterol phendimetrazine tartrate Viibryd Levalbuterol Tartrate HFA phentermine HCl Vraylar Lonhala Magnair Qsymia ziprasidone HCl Metaproterenol Sulfate Saxenda ziprasidone mesylate montelukast sodium Xenical Zyprexa Relprevv Perforomist Proair Digihaler OSTEOPOROSIS Proair Respiclick alendronate sodium Pulmicort Flexhaler calcitonin salmon Qvar Fosamax Plus D Qvar Redihaler Ibrandonate sodium Seebri Neohaler raloxifene HCl Serevent Diskus risedronate sodium Spiriva Handihaler risedronate sodium DR Spiriva Respimat Stiolto Respimat OTHER PREVENTIVE PRODUCTS Striverdi Respimat aspirin Symbicort bowel preparations Theo-24 cromolyn Theochron fluoride dental products theophylline folic acid theophylline CR hormonal contraceptives theophylline ER smoking deterrents Trelegy Ellipta vaccines Tudorza Pressair vitamins Utibron Neohaler Ventolin HFA PEAK FLOW METER wixela inhub Peak Flow Meter Xopenex HFA Yupelri PRENATAL VITAMINS zafirlukast Prenatal Vitamins zileuton ER Zyflo PULMONARY - ASTHMA/CHRONIC OBSTRUCTIVE PULMONARY DISEASE THROMBOTIC STROKE PREVENTION Advair HFA aspirin/dipyridamole ER Aerospan Brilinta Airduo Respiclick cilostazol albuterol sulfate clopidogrel albuterol sulfate ER dipyridamole albuterol sulfate HFA prasugrel KEY: CR = controlled release | DR = delayed release | ER = extended release HCl = hydrochloride | HCTZ = hydrochlorothiazide | HFA = hydrofluoroalkane LA = long acting | ODT = oral disintegrating tablet | XR = extended release ELIXIR • 2021 ENHANCED HDHP LIST | 3 Medications are categorized by common therapeutic conditions in this Preventive Therapy Drug List for ease of reference only. These categories do not determine coverage for the medication for your condition. Your benefit plan determines how these medications may be covered for you and at what cost. Therefore, certain products, categories, strengths, dosage forms, or formulations may not be covered. Please note that over-the-counter products require a prescription. The ability to obtain medications listed on this Preventive Therapy Drug may be limited by federal, state, or local laws or regulations such as expiration dates or limits on the number of refills. If there are differences between your plan design and this Preventive Therapy Drug List, your plan design will dictate final coverage status. If you have any questions regarding the coverage of any particular drug under your benefit program, you may: 1. Call the Member Services number located on the back of your prescription drug identification card; 2. Refer to your plan-specific documents; or 3. Contact your plan administrator for further information. This list is periodically reviewed and updated. 10/5/2020 About Elixir | elixirsolutions.com With the unique ability to optimize the full pharmacy care experience, Elixir is crafting solutions for today’s pharmacy benefits challenges. For more information, visit elixirsolutions.com. © 2020 Elixir Rx Solutions, LLC - All Rights Reserved. 20-4984.
Load more

Recommended publications
  • 2020 Prior Authorization Criteria
    2020 PRIOR AUTHORIZATION CRITERIA TABLE OF CONTENTS abiraterone tablet ...................................................................................................................... 217 ABRAXANE .............................................................................................................................. 131 ACTIMMUNE .............................................................................................................................. 14 ADASUVE ................................................................................................................................... 27 ADEMPAS ................................................................................................................................ 197 AFINITOR ................................................................................................................................. 217 AFINITOR DISPERZ ................................................................................................................. 217 AIMOVIG ..................................................................................................................................... 15 ALECENSA ............................................................................................................................... 217 ALIMTA ..................................................................................................................................... 131 ALIQOPA .................................................................................................................................
    [Show full text]
  • M2021: Pharmacogenetic Testing
    Pharmacogenetic Testing Policy Number: AHS – M2021 – Pharmacogenetic Prior Policy Name and Number, as applicable: Testing • M2021 – Cytochrome P450 Initial Presentation Date: 06/16/2021 Revision Date: N/A I. Policy Description Pharmacogenetics is defined as the study of variability in drug response due to heredity (Nebert, 1999). Cytochrome (CYP) P450 enzymes are a class of enzymes essential in the synthesis and breakdown metabolism of various molecules and chemicals. Found primarily in the liver, these enzymes are also essential for the metabolism of many medications. CYP P450 are essential to produce many biochemical building blocks, such as cholesterol, fatty acids, and bile acids. Additional cytochrome P450 are involved in the metabolism of drugs, carcinogens, and internal substances, such as toxins formed within cells. Mutations in CYP P450 genes can result in the inability to properly metabolize medications and other substances, leading to increased levels of toxic substances in the body. Approximately 58 CYP genes are in humans (Bains, 2013; Tantisira & Weiss, 2019). Thiopurine methyltransferase (TPMT) is an enzyme that methylates azathioprine, mercaptopurine and thioguanine into active thioguanine nucleotide metabolites. Azathioprine and mercaptopurine are used for treatment of nonmalignant immunologic disorders; mercaptopurine is used for treatment of lymphoid malignancies; and thioguanine is used for treatment of myeloid leukemias (Relling et al., 2011). Dihydropyrimidine dehydrogenase (DPD), encoded by the gene DPYD, is a rate-limiting enzyme responsible for fluoropyrimidine catabolism. The fluoropyrimidines (5-fluorouracil and capecitabine) are drugs used in the treatment of solid tumors, such as colorectal, breast, and aerodigestive tract tumors (Amstutz et al., 2018). A variety of cell surface proteins, such as antigen-presenting molecules and other proteins, are encoded by the human leukocyte antigen genes (HLAs).
    [Show full text]
  • 2021 SELECT EX FORMULARY the Following Is a List of the Most Commonly Prescribed Brand and Generic Medications
    2021 SELECT EX FORMULARY The following is a list of the most commonly prescribed brand and generic medications. It represents an abbreviated version of the formulary list that is at the core of your prescription drug benefit plan. The list is not all-inclusive and does not guarantee coverage. Some preferred medications overlap with other clinical programs and may not be covered. In addition to drugs on this list, the majority of generic medications are covered under your plan and you are encouraged to ask your doctor to prescribe generic drugs whenever appropriate. Search complete formulary drug information at elixirsolutions.com. PLEASE NOTE: Preferred brand drugs may move to non-preferred status if a generic version becomes available during the year. Any medication approved to enter the market will not be covered until reviewed by Elixir. Not all drugs listed are covered by all prescription drug benefit programs. For specific questions about your coverage, please visit elixirsolutions.com. A B CILOXAN OINTMENT digoxin abacavir tablet balsalazide CIMDUO diltiazem ER (except generics for abacavir-lamivudine BAQSIMI cinacalcet CARDIZEM LA) ABILIFY MAINTENA [INJ] BASAGLAR [INJ] ciprofloxacin dimethyl fumarate DR* abiraterone* BD ULTRAFINE INSULIN SYRINGES ciprofloxacin-dexamethasone diphenoxylate-atropine acetic acid & NEEDLES citalopram dipyridamole ER-aspirin acitretin BELBUCA CITRANATAL divalproex sodium ACUVAIL BELSOMRA clarithromycin divalproex sodium ER acyclovir capsule, tablet benzonatate (except NDCs: clarithromycin ER DIVIGEL
    [Show full text]
  • Different Beta-Blocking Effects of Carvedilol and Bisoprolol in Humans
    Journal of Clinical and Basic Cardiology An Independent International Scientific Journal Journal of Clinical and Basic Cardiology 2001; 4 (1), 53-56 Different beta-blocking effects of carvedilol and bisoprolol in humans Koshucharova G, Klein W, Lercher P, Maier R, Stepan V Stoschitzky K, Zweiker R Homepage: www.kup.at/jcbc Online Data Base Search for Authors and Keywords Indexed in Chemical Abstracts EMBASE/Excerpta Medica Krause & Pachernegg GmbH · VERLAG für MEDIZIN und WIRTSCHAFT · A-3003 Gablitz/Austria ORIGINAL PAPERS, CLINICAL CARDIOLOGY Different Beta-Blocking Effects of Carvedilol and Bisoprolol J Clin Basic Cardiol 2001; 4: 53 Different Beta-Blocking Effects of Carvedilol and Bisoprolol in Humans G. Koshucharova, R. Zweiker, R. Maier, P. Lercher, V. Stepan, W. Klein, K. Stoschitzky Bisoprolol is a beta1-selective beta-adrenergic antagonist while carvedilol is a non-selective beta-blocker with additional blockade of alpha1-adrenoceptors. Administration of bisoprolol has been shown to cause up-regulation of β-adrenoceptor density and to decrease nocturnal melatonin release, whereas carvedilol lacks these typical effects of beta-blocking drugs. The objective of the present study was to investigate beta-blocking effects of bisoprolol and carvedilol in healthy subjects. We compared the effects of single oral doses of clinically recommended amounts of bisoprolol (2.5, 5 and 10 mg) and carvedilol (25, 50 and 100 mg) to those of placebo in a randomised, double-blind, cross-over study in 12 healthy male volun- teers. Three hours after oral administration of the drugs heart rate and blood pressure were measured at rest, after 10 min. of exercise, and after 15 min.
    [Show full text]
  • Tall Man Lettering List REPORT DECEMBER 2013 1
    Tall Man Lettering List REPORT DECEMBER 2013 1 TALL MAN LETTERING LIST REPORT WWW.HQSC.GOVT.NZ Published in December 2013 by the Health Quality & Safety Commission. This document is available on the Health Quality & Safety Commission website, www.hqsc.govt.nz ISBN: 978-0-478-38555-7 (online) Citation: Health Quality & Safety Commission. 2013. Tall Man Lettering List Report. Wellington: Health Quality & Safety Commission. Crown copyright ©. This copyright work is licensed under the Creative Commons Attribution-No Derivative Works 3.0 New Zealand licence. In essence, you are free to copy and distribute the work (including other media and formats), as long as you attribute the work to the Health Quality & Safety Commission. The work must not be adapted and other licence terms must be abided. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nd/3.0/nz/ Copyright enquiries If you are in doubt as to whether a proposed use is covered by this licence, please contact: National Medication Safety Programme Team Health Quality & Safety Commission PO Box 25496 Wellington 6146 ACKNOWLEDGEMENTS The Health Quality & Safety Commission acknowledges the following for their assistance in producing the New Zealand Tall Man lettering list: • The Australian Commission on Safety and Quality in Health Care for advice and support in allowing its original work to be either reproduced in whole or altered in part for New Zealand as per its copyright1 • The Medication Safety and Quality Program of Clinical Excellence Commission, New South
    [Show full text]
  • 4 Supplementary File
    Supplemental Material for High-throughput screening discovers anti-fibrotic properties of Haloperidol by hindering myofibroblast activation Michael Rehman1, Simone Vodret1, Luca Braga2, Corrado Guarnaccia3, Fulvio Celsi4, Giulia Rossetti5, Valentina Martinelli2, Tiziana Battini1, Carlin Long2, Kristina Vukusic1, Tea Kocijan1, Chiara Collesi2,6, Nadja Ring1, Natasa Skoko3, Mauro Giacca2,6, Giannino Del Sal7,8, Marco Confalonieri6, Marcello Raspa9, Alessandro Marcello10, Michael P. Myers11, Sergio Crovella3, Paolo Carloni5, Serena Zacchigna1,6 1Cardiovascular Biology, 2Molecular Medicine, 3Biotechnology Development, 10Molecular Virology, and 11Protein Networks Laboratories, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, 34149, Trieste, Italy 4Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy 5Computational Biomedicine Section, Institute of Advanced Simulation IAS-5 and Institute of Neuroscience and Medicine INM-9, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany 6Department of Medical, Surgical and Health Sciences, University of Trieste, 34149 Trieste, Italy 7National Laboratory CIB, Area Science Park Padriciano, Trieste, 34149, Italy 8Department of Life Sciences, University of Trieste, Trieste, 34127, Italy 9Consiglio Nazionale delle Ricerche (IBCN), CNR-Campus International Development (EMMA- INFRAFRONTIER-IMPC), Rome, Italy This PDF file includes: Supplementary Methods Supplementary References Supplementary Figures with legends 1 – 18 Supplementary Tables with legends 1 – 5 Supplementary Movie legends 1, 2 Supplementary Methods Cell culture Primary murine fibroblasts were isolated from skin, lung, kidney and hearts of adult CD1, C57BL/6 or aSMA-RFP/COLL-EGFP mice (1) by mechanical and enzymatic tissue digestion. Briefly, tissue was chopped in small chunks that were digested using a mixture of enzymes (Miltenyi Biotec, 130- 098-305) for 1 hour at 37°C with mechanical dissociation followed by filtration through a 70 µm cell strainer and centrifugation.
    [Show full text]
  • The Role of Epinephrine in the Treatment of Anaphylaxis Anne K
    The Role of Epinephrine in the Treatment of Anaphylaxis Anne K. Ellis, MD, and James H. Day, MD, FRCP(C) Address Beneficial Effects of Epinephrine Division of Allergy, Kingston General Hospital, 76 Stuart Street, in Anaphylaxis Kingston, ON K7L 2V7, Canada. Epinephrine is both an alpha (α) and a beta (β) adrener- E-mail: [email protected] gic receptor agonist. Through α-adrenergic stimulation, Current Allergy and Asthma Reports 2003, 3:11–14 epinephrine increases peripheral vascular resistance, Current Science Inc. ISSN 1529-7322 Copyright © 2003 by Current Science Inc. improving blood pressure and coronary artery perfusion, reversing peripheral vasodilation, and decreasing angioedema and urticaria [5]. β-1 adrenergic stimulation Epinephrine is the cornerstone of anaphylaxis manage- has positive inotropic and chronotropic effects on the ment. Its administration should be immediate upon evi- myocardium, and β-2 adrenergic effects include bron- dence of the occurrence of anaphylaxis. Delays in chodilation [6]. β-adrenergic receptors also increase administration may be fatal. The most appropriate admin- intracellular cyclic adenosine monophosphate (cAMP) istration is 0.3 to 0.5 mL of 1:1000 dilution intramuscu- production in mast cells and basophils, which inhibits larly for adults and 0.01 mg/kg for children, given in the further inflammatory mediator release [7,8]. lateral thigh. Patients with known anaphylactic reactivity should be prescribed an epinephrine auto-injector to be carried at all times for treatment of potential recur- Dosage and Routes of Administration rences. Education of the patient or parent regarding the for Epinephrine proper use of this tool is paramount. Some discrepancy exists in the literature concerning the appropriate dosage of epinephrine for anaphylaxis.
    [Show full text]
  • IHS National Pharmacy & Therapeutics Committee National
    IHS National Pharmacy & Therapeutics Committee National Core Formulary; Last Updated: 09/23/2021 **Note: Medications in GREY indicate removed items.** Generic Medication Name Pharmacological Category (up-to-date) Formulary Brief (if Notes / Similar NCF Active? available) Miscellaneous Medications Acetaminophen Analgesic, Miscellaneous Yes Albuterol nebulized solution Beta2 Agonist Yes Albuterol, metered dose inhaler Beta2 Agonist NPTC Meeting Update *Any product* Yes (MDI) (Nov 2017) Alendronate Bisphosphonate Derivative Osteoporosis (2016) Yes Allopurinol Antigout Agent; Xanthine Oxidase Inhibitor Gout (2016) Yes Alogliptin Antidiabetic Agent, Dipeptidyl Peptidase 4 (DPP-4) Inhibitor DPP-IV Inhibitors (2019) Yes Anastrozole Antineoplastic Agent, Aromatase Inhibitor Yes Aspirin Antiplatelet Agent; Nonsteroidal Anti-Inflammatory Drug; Salicylate Yes Azithromycin Antibiotic, Macrolide STIs - PART 1 (2021) Yes Calcium Electrolyte supplement *Any formulation* Yes Carbidopa-Levodopa (immediate Anti-Parkinson Agent; Decarboxylase Inhibitor-Dopamine Precursor Parkinson's Disease Yes release) (2019) Clindamycin, topical ===REMOVED from NCF=== (See Benzoyl Peroxide AND Removed January No Clindamycin, topical combination) 2020 Corticosteroid, intranasal Intranasal Corticosteroid *Any product* Yes Cyanocobalamin (Vitamin B12), Vitamin, Water Soluble Hematologic Supplements Yes oral (2016) Printed on 09/25/2021 Page 1 of 18 National Core Formulary; Last Updated: 09/23/2021 Generic Medication Name Pharmacological Category (up-to-date) Formulary Brief
    [Show full text]
  • Guideline (S2k) on Acute Therapy and Management of Anaphylaxis: 2021 Update
    guidelines Allergo J Int (2021) 30:1–25 https://doi.org/10.1007/s40629-020-00158-y Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE) Johannes Ring · Kirsten Beyer · Tilo Biedermann · Andreas Bircher · Matthias Fischer · Thomas Fuchs · Axel Heller · Florian Hoffmann · Isidor Huttegger · Thilo Jakob · Ludger Klimek · Matthias V. Kopp · Claudia Kugler · Lars Lange · Oliver Pfaar · Ernst Rietschel · Franziska Rueff · Sabine Schnadt · Roland Seifert · Britta Stöcker · Regina Treudler · Christian Vogelberg · Thomas Werfel · Margitta Worm · Helmut Sitter · Knut Brockow Published online: 28 January 2021 © The Author(s) 2021 Keywords Anaphylaxis · Food allergy · Drug LT Leukotriene
    [Show full text]
  • A Concise Guide to Treating Painful Oral Lesions
    Drugs Used to Treat Osteoporosis and Bone Cancer Perio & Implant Centers The Team for of the Monterey Bay (831) 648-8800 Jochen P. Pechak, DDS, MSD in Silicon Valley (408) 738-3423 Which May Cause Osteonecrosis of the Jaws mobile: www.DrPechakapp.com he many bisphosphonates and monoclonal antibodies which are used to treat osteoporosis and bone cancer often web: GumsRus.com causeDrugsDrugs osteonecrosis Used Used of the to jaws.to Treat AsTreat dental clinicians,Osteoporosis Osteoporosis it is important that and andwe are Bone awareBone of this Cancers Cancers side effect before Ttreating our patients who are taking these drugs. The tables below summarize these drugs, the route these drugs are administered, andWhich Whichtheir likelihood May May of causing Cause Cause osteonecrosis Osteonecrosis Osteonecrosis of the jaws as reported byof of Dr. the theRobert Jaws JawsMarx at the University of Miami Division of Oral and Maxillofacial Surgery. PDL tm Osteoporosis Drugs Drugs Osteoporosis Used to Treat Drugs Osteoporosis PerioDontaLetter Jochen P. Pechak, DDS, MSD, Periodontics and Implant Dentistry Spring DrugDrug ClassificationClassification ActionAction DoseDose RouteRoute %% of of ReportedReported CasesCases of of OsteonecrosisOsteonecrosis AlendronateAlendronate BisphosphonateBisphosphonate OsteoclastOsteoclast 7070 mg/wk mg/wk OralOral 8282%% From Our Office A Concise Guide to Treating (Fosamax(Fosamax ToxicityToxicity to Yours... Generic)Generic) Painful Oral Lesions ResidronateResidronate BisphosphonateBisphosphonate OsteoclastOsteoclast 3535 mg/wk mg/wk OralOral 1%1% As dentists specializing in treat- (Actonel Toxicity (Actonel Toxicity ment of diseases of the oral cavity atients present frequently with Treating Cold Sores Atelvia)Atelvia) and associated structures, we are painful oral lesions. They are often also called upon to treat pain- IbandronateIbandronate BisphosphonateBisphosphonate OsteoclastOsteoclast 150150 mg/mos mg/mos OralOral 1%1% usually not serious, but patients And Canker Sores (Boniva) Toxicity IV ful oral lesions in the mouth.
    [Show full text]
  • Mutasem Rawas.Qalaji
    FORMULATION AND ASSESSMENT OF FAST- DISINTEGRATING SUBLINGUAL EPINEPHRINE TABLETS FOR TI.IE POTENTIAI- EMERGENCY TREATMENT OF ANAPHYLAXIS By MUTASEM RAWAS.QALAJI A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY FACULTY OF PHARMACY UNIVERSITY OF MANITOBA WINNIPEG, MANITOBA, CANADA JUNE, 2006 THE UNIVERSITY OF MANITOBA FACULTY OF GRADUATE STUDIES COPYRIGHT PERMISSION Formulation and Assessment of Fast-Disintegrating Sublingual Epinephrine Tablets for the Potential Emergency Treatment of Anaphylaxis By Mutasem Rawas-Qalaji A Thesis/Practicum submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fïlfitlment of the requirement of the degree of Doctor of Philosophy Mutasem Rawas-Qalaji @ 2006 Permission has been granted to the Library of the University of Manitoba to lend or sell copies of this thesis/practicum, to the National Library of Canada to microfilm this thesis and to lend or sell copies of the film, and to University Microfilms Inc. to publish an abstract of this thesis/practicum. This reproduction or copy of this thesis has been made available by authority of the copyright owner solely for the purpose of private study and research, and may only be reproduced and copied as permitted by copyright laws or with express written authorization from the copyright o\ilner. DEDICATION To my father Mohamad Rawas-ealaji and my mother wedad Duqsi (in memoriam) lwould like to dedicate this work. ABSTRACT Objectives; To formulate, characterize, and evaluate the stability of sublingual (sL) epinephrine (E) tablets that are bioequivatent to E 0.3 mg intramuscular injection (lM) for the feasibility of SL E administration for the potential out-of-hospital emergency treatment of anaphylaxis.
    [Show full text]
  • Making an Elderberry Syrup Or Elixir
    Making an Elderberry Syrup or Elixir Herbal syrups are water extractions of herbs (usually decoctions—see below) that are concentrated with a sweetener (preferably organic white sugar or raw honey). This sweetener provides a bit of nutritional support as a carbohydrate and also acts as a preservative. The concentration of sugar is particularly important when making syrups and elixirs; when in water, sugar acts as a food source for micro-organisms (especially molds and yeasts). However, at a high enough concentration, the sugar actually restricts the growth ability of micro-organisms. So we are aiming to get our syrup to be saturated enough to preserve, but not so saturated that the sugar overwhelms the liquid and causes crystallization. When preparing a syrup, one of the following ratios should be used: 1 part decoction : 1 part sweetener 1 part decoction : 2 parts sweetener I tend to follow the 1 part water : 1 part sweetener suggestion, as the 1 : 2 ratio is too sweet for me. But I have access to a refrigerator, which will also help with preservation. If you are keeping your syrup at room temperature, the 1:2 ratio is best. Syrups are a great, palatable method for delivery of herbal medicines (especially for children), and are also a great way to mask the flavor of less tasty tinctures--just combine the tincture and the syrup and you get the medicinal benefits of both. Preserving syrups with honey is also a great way to combine the medicinal benefits of the honey with the herbs that are being used. Do not give syrups preserved with honey to children under the age of one.
    [Show full text]